APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha L-Iduronidase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alpha L-Iduronidase Industry Growth and Trends Forecast to 2032

2 January 2026109 pages

Choose your research edition.

Industry ResearchAlpha L-Iduronidase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha L-Iduronidase Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Alpha L-Iduronidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha L-Iduronidase Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha L-Iduronidase Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alpha L-Iduronidase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha L-Iduronidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha L-Iduronidase include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc and Ossianix Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alpha L-Iduronidase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alpha L-Iduronidase market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alpha L-Iduronidase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alpha L-Iduronidase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alpha L-Iduronidase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alpha L-Iduronidase Market by Company

ArmaGen Inc

BioStrategies LC

Denali Therapeutics Inc

EdiGene Inc

Gain Therapeutics Inc

Immusoft Corp

JCR Pharmaceuticals Co Ltd

Orchard Therapeutics Plc

Ossianix Inc

Rain Bio Inc

RegenxBio Inc

Tega Therapeutics Inc

Alpha L-Iduronidase Segment by Type

IDUA

EC 3.2.1.76

Alpha L-Iduronidase Segment by Application

Oncology

Dermatology

Immunology

Musculoskeletal Disorders

Alpha L-Iduronidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha L-Iduronidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha L-Iduronidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha L-Iduronidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha L-Iduronidase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alpha L-Iduronidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IDUA Table 2. Major Company of EC 3.2.1.76 Table 3. Global Alpha L-Iduronidase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 5. Global Alpha L-Iduronidase Sales Market Share in Volume by Type (2021-2026) Table 6. Global Alpha L-Iduronidase Sales by Type (2021-2026) & (US$ Million) Table 7. Global Alpha L-Iduronidase Sales Market Share in Value by Type (2021-2026) Table 8. Global Alpha L-Iduronidase Price by Type (2021-2026) & (US$/Unit) Table 9. Global Alpha L-Iduronidase Sales by Type (2027-2032) & (K Units) Table 10. Global Alpha L-Iduronidase Sales Market Share in Volume by Type (2027-2032) Table 11. Global Alpha L-Iduronidase Sales by Type (2027-2032) & (US$ Million) Table 12. Global Alpha L-Iduronidase Sales Market Share in Value by Type (2027-2032) Table 13. Global Alpha L-Iduronidase Price by Type (2027-2032) & (US$/Unit) Table 14. North America Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 15. North America Alpha L-Iduronidase Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 17. Europe Alpha L-Iduronidase Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Alpha L-Iduronidase Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 21. Latin America Alpha L-Iduronidase Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Alpha L-Iduronidase Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Alpha L-Iduronidase Sales by Type (2021-2026) & (US$ Million) Table 24. Alpha L-Iduronidase Industry Trends Table 25. Alpha L-Iduronidase Industry Drivers Table 26. Alpha L-Iduronidase Industry Opportunities and Challenges Table 27. Alpha L-Iduronidase Industry Restraints Table 28. Global Alpha L-Iduronidase Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Alpha L-Iduronidase Revenue Market Share by Company (2021-2026) Table 30. Global Alpha L-Iduronidase Sales by Company (2021-2026) & (K Units) Table 31. Global Alpha L-Iduronidase Sales Share by Company (2021-2026) Table 32. Global Alpha L-Iduronidase Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Alpha L-Iduronidase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Alpha L-Iduronidase Major Company Production Sites and Headquarters Table 35. Global Alpha L-Iduronidase Company, Product Type & Application Table 36. Global Alpha L-Iduronidase Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Alpha L-Iduronidase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Alpha L-Iduronidase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Alpha L-Iduronidase Sales by Region (2021-2026) & (K Units) Table 41. Global Alpha L-Iduronidase Sales Market Share in Volume by Region (2021-2026) Table 42. Global Alpha L-Iduronidase Sales by Region (2021-2026) & (US$ Million) Table 43. Global Alpha L-Iduronidase Sales Market Share in Value by Region (2021-2026) Table 44. Global Alpha L-Iduronidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Alpha L-Iduronidase Sales by Region (2027-2032) & (K Units) Table 46. Global Alpha L-Iduronidase Sales Market Share in Volume by Region (2027-2032) Table 47. Global Alpha L-Iduronidase Sales by Region (2027-2032) & (US$ Million) Table 48. Global Alpha L-Iduronidase Sales Market Share in Value by Region (2027-2032) Table 49. Global Alpha L-Iduronidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Alpha L-Iduronidase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 52. Global Alpha L-Iduronidase Sales Market Share in Volume by Application (2021-2026) Table 53. Global Alpha L-Iduronidase Sales by Application (2021-2026) & (US$ Million) Table 54. Global Alpha L-Iduronidase Sales Market Share in Value by Application (2021-2026) Table 55. Global Alpha L-Iduronidase Price by Application (2021-2026) & (US$/Unit) Table 56. Global Alpha L-Iduronidase Sales by Application (2027-2032) & (K Units) Table 57. Global Alpha L-Iduronidase Sales Market Share in Volume by Application (2027-2032) Table 58. Global Alpha L-Iduronidase Sales by Application (2027-2032) & (US$ Million) Table 59. Global Alpha L-Iduronidase Sales Market Share in Value by Application (2027-2032) Table 60. Global Alpha L-Iduronidase Price by Application (2027-2032) & (US$/Unit) Table 61. North America Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 62. North America Alpha L-Iduronidase Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 64. Europe Alpha L-Iduronidase Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Alpha L-Iduronidase Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 68. Latin America Alpha L-Iduronidase Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Alpha L-Iduronidase Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Alpha L-Iduronidase Sales by Application (2021-2026) & (US$ Million) Table 71. ArmaGen Inc Company Information Table 72. ArmaGen Inc Business Overview Table 73. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ArmaGen Inc Alpha L-Iduronidase Product Portfolio Table 75. ArmaGen Inc Recent Development Table 76. BioStrategies LC Company Information Table 77. BioStrategies LC Business Overview Table 78. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. BioStrategies LC Alpha L-Iduronidase Product Portfolio Table 80. BioStrategies LC Recent Development Table 81. Denali Therapeutics Inc Company Information Table 82. Denali Therapeutics Inc Business Overview Table 83. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolio Table 85. Denali Therapeutics Inc Recent Development Table 86. EdiGene Inc Company Information Table 87. EdiGene Inc Business Overview Table 88. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. EdiGene Inc Alpha L-Iduronidase Product Portfolio Table 90. EdiGene Inc Recent Development Table 91. Gain Therapeutics Inc Company Information Table 92. Gain Therapeutics Inc Business Overview Table 93. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolio Table 95. Gain Therapeutics Inc Recent Development Table 96. Immusoft Corp Company Information Table 97. Immusoft Corp Business Overview Table 98. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Immusoft Corp Alpha L-Iduronidase Product Portfolio Table 100. Immusoft Corp Recent Development Table 101. JCR Pharmaceuticals Co Ltd Company Information Table 102. JCR Pharmaceuticals Co Ltd Business Overview Table 103. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolio Table 105. JCR Pharmaceuticals Co Ltd Recent Development Table 106. Orchard Therapeutics Plc Company Information Table 107. Orchard Therapeutics Plc Business Overview Table 108. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolio Table 110. Orchard Therapeutics Plc Recent Development Table 111. Ossianix Inc Company Information Table 112. Ossianix Inc Business Overview Table 113. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Ossianix Inc Alpha L-Iduronidase Product Portfolio Table 115. Ossianix Inc Recent Development Table 116. Rain Bio Inc Company Information Table 117. Rain Bio Inc Business Overview Table 118. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Rain Bio Inc Alpha L-Iduronidase Product Portfolio Table 120. Rain Bio Inc Recent Development Table 121. RegenxBio Inc Company Information Table 122. RegenxBio Inc Business Overview Table 123. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. RegenxBio Inc Alpha L-Iduronidase Product Portfolio Table 125. RegenxBio Inc Recent Development Table 126. Tega Therapeutics Inc Company Information Table 127. Tega Therapeutics Inc Business Overview Table 128. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolio Table 130. Tega Therapeutics Inc Recent Development Table 131. North America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 133. North America Alpha L-Iduronidase Sales Market Share by Country (2021-2026) Table 134. North America Alpha L-Iduronidase Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Alpha L-Iduronidase Sales Market Share Forecast by Country (2027-2032) Table 136. North America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Alpha L-Iduronidase Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Alpha L-Iduronidase Market Share by Country (2021-2026) Table 139. North America Alpha L-Iduronidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Alpha L-Iduronidase Market Share Forecast by Country (2027-2032) Table 141. Europe Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 143. Europe Alpha L-Iduronidase Sales Market Share by Country (2021-2026) Table 144. Europe Alpha L-Iduronidase Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Alpha L-Iduronidase Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Alpha L-Iduronidase Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Alpha L-Iduronidase Market Share by Country (2021-2026) Table 149. Europe Alpha L-Iduronidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Alpha L-Iduronidase Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Alpha L-Iduronidase Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Alpha L-Iduronidase Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Alpha L-Iduronidase Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Alpha L-Iduronidase Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Alpha L-Iduronidase Market Share by Country (2021-2026) Table 159. Asia-Pacific Alpha L-Iduronidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Alpha L-Iduronidase Market Share Forecast by Country (2027-2032) Table 161. Latin America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 163. Latin America Alpha L-Iduronidase Sales Market Share by Country (2021-2026) Table 164. Latin America Alpha L-Iduronidase Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Alpha L-Iduronidase Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Alpha L-Iduronidase Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Alpha L-Iduronidase Market Share by Country (2021-2026) Table 169. Latin America Alpha L-Iduronidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Alpha L-Iduronidase Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Alpha L-Iduronidase Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Alpha L-Iduronidase Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Alpha L-Iduronidase Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Alpha L-Iduronidase Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Alpha L-Iduronidase Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Alpha L-Iduronidase Market Share by Country (2021-2026) Table 179. Middle East and Africa Alpha L-Iduronidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Alpha L-Iduronidase Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Alpha L-Iduronidase Distributors List Table 184. Alpha L-Iduronidase Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Alpha L-Iduronidase Image Figure 2. Global Alpha L-Iduronidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha L-Iduronidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha L-Iduronidase Sales (2021-2032) & (K Units) Figure 5. IDUA Image Figure 6. Global IDUA Sales YoY Growth (2021-2032) & (K Units) Figure 7. EC 3.2.1.76 Image Figure 8. Global EC 3.2.1.76 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Alpha L-Iduronidase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Alpha L-Iduronidase Market Share by Type 2025 VS 2032 Figure 11. North America Alpha L-Iduronidase Sales Market Share in Volume by Type in 2025 Figure 12. North America Alpha L-Iduronidase Sales Market Share in Value by Type in 2025 Figure 13. Europe Alpha L-Iduronidase Sales Market Share in Volume by Type in 2025 Figure 14. Europe Alpha L-Iduronidase Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Value by Type in 2025 Figure 17. Latin America Alpha L-Iduronidase Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Alpha L-Iduronidase Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Alpha L-Iduronidase Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oncology Image Figure 24. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 25. Dermatology Image Figure 26. Global Dermatology Sales YoY Growth (2021-2032) & (K Units) Figure 27. Immunology Image Figure 28. Global Immunology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Musculoskeletal Disorders Image Figure 30. Global Musculoskeletal Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Alpha L-Iduronidase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Alpha L-Iduronidase Market Share by Application 2025 VS 2032 Figure 33. North America Alpha L-Iduronidase Sales Market Share in Volume by Application in 2025 Figure 34. North America Alpha L-Iduronidase Sales Market Share in Value by Application in 2025 Figure 35. Europe Alpha L-Iduronidase Sales Market Share in Volume by Application in 2025 Figure 36. Europe Alpha L-Iduronidase Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Alpha L-Iduronidase Sales Market Share in Value by Application in 2025 Figure 39. Latin America Alpha L-Iduronidase Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Alpha L-Iduronidase Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Alpha L-Iduronidase Sales Market Share in Value by Application in 2025 Figure 43. North America Alpha L-Iduronidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Alpha L-Iduronidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Alpha L-Iduronidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Alpha L-Iduronidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Alpha L-Iduronidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Alpha L-Iduronidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Alpha L-Iduronidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Alpha L-Iduronidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Alpha L-Iduronidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Alpha L-Iduronidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Alpha L-Iduronidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Alpha L-Iduronidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Alpha L-Iduronidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Alpha L-Iduronidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Alpha L-Iduronidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Alpha L-Iduronidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Alpha L-Iduronidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Alpha L-Iduronidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Alpha L-Iduronidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Alpha L-Iduronidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Alpha L-Iduronidase Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Alpha L-Iduronidase Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • IDUA
  • EC 3.2.1.76
Applications
  • Oncology
  • Dermatology
  • Immunology
  • Musculoskeletal Disorders
Companies covered
  • ArmaGen Inc
  • BioStrategies LC
  • Denali Therapeutics Inc
  • EdiGene Inc
  • Gain Therapeutics Inc
  • Immusoft Corp
  • JCR Pharmaceuticals Co Ltd
  • Orchard Therapeutics Plc
  • Ossianix Inc
  • Rain Bio Inc
  • RegenxBio Inc
  • Tega Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha L-Iduronidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alpha L-Iduronidase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alpha L-Iduronidase Market by Type
  6. 1.3.1 IDUA
  7. 1.3.2 EC 3.2.1.76
  8. 1.4 Global Alpha L-Iduronidase Market Size by Type
  9. 1.4.1 Global Alpha L-Iduronidase Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Alpha L-Iduronidase Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Alpha L-Iduronidase Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Alpha L-Iduronidase Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Alpha L-Iduronidase Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Alpha L-Iduronidase Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Alpha L-Iduronidase Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Alpha L-Iduronidase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alpha L-Iduronidase Industry Trends
  2. 2.2 Alpha L-Iduronidase Industry Drivers
  3. 2.3 Alpha L-Iduronidase Industry Opportunities and Challenges
  4. 2.4 Alpha L-Iduronidase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alpha L-Iduronidase Revenue (2021-2026)
  2. 3.2 Global Top Players by Alpha L-Iduronidase Sales (2021-2026)
  3. 3.3 Global Top Players by Alpha L-Iduronidase Price (2021-2026)
  4. 3.4 Global Alpha L-Iduronidase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha L-Iduronidase Major Company Production Sites & Headquarters
  6. 3.6 Global Alpha L-Iduronidase Company, Product Type & Application
  7. 3.7 Global Alpha L-Iduronidase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha L-Iduronidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha L-Iduronidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha L-Iduronidase Tier 1, Tier 2, and Tier 3
4 Alpha L-Iduronidase Regional Status and Outlook
  1. 4.1 Global Alpha L-Iduronidase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alpha L-Iduronidase Historic Market Size by Region
  3. 4.2.1 Global Alpha L-Iduronidase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alpha L-Iduronidase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alpha L-Iduronidase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alpha L-Iduronidase Forecasted Market Size by Region
  7. 4.3.1 Global Alpha L-Iduronidase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alpha L-Iduronidase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alpha L-Iduronidase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alpha L-Iduronidase by Application
  1. 5.1 Alpha L-Iduronidase Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Dermatology
  4. 5.1.3 Immunology
  5. 5.1.4 Musculoskeletal Disorders
  6. 5.2 Global Alpha L-Iduronidase Market Size by Application
  7. 5.2.1 Global Alpha L-Iduronidase Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Alpha L-Iduronidase Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Alpha L-Iduronidase Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Alpha L-Iduronidase Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Alpha L-Iduronidase Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Alpha L-Iduronidase Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Alpha L-Iduronidase Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Alpha L-Iduronidase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ArmaGen Inc
  2. 6.1.1 ArmaGen Inc Company Information
  3. 6.1.2 ArmaGen Inc Business Overview
  4. 6.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ArmaGen Inc Alpha L-Iduronidase Product Portfolio
  6. 6.1.5 ArmaGen Inc Recent Developments
  7. 6.2 BioStrategies LC
  8. 6.2.1 BioStrategies LC Company Information
  9. 6.2.2 BioStrategies LC Business Overview
  10. 6.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BioStrategies LC Alpha L-Iduronidase Product Portfolio
  12. 6.2.5 BioStrategies LC Recent Developments
  13. 6.3 Denali Therapeutics Inc
  14. 6.3.1 Denali Therapeutics Inc Company Information
  15. 6.3.2 Denali Therapeutics Inc Business Overview
  16. 6.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolio
  18. 6.3.5 Denali Therapeutics Inc Recent Developments
  19. 6.4 EdiGene Inc
  20. 6.4.1 EdiGene Inc Company Information
  21. 6.4.2 EdiGene Inc Business Overview
  22. 6.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 EdiGene Inc Alpha L-Iduronidase Product Portfolio
  24. 6.4.5 EdiGene Inc Recent Developments
  25. 6.5 Gain Therapeutics Inc
  26. 6.5.1 Gain Therapeutics Inc Company Information
  27. 6.5.2 Gain Therapeutics Inc Business Overview
  28. 6.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolio
  30. 6.5.5 Gain Therapeutics Inc Recent Developments
  31. 6.6 Immusoft Corp
  32. 6.6.1 Immusoft Corp Company Information
  33. 6.6.2 Immusoft Corp Business Overview
  34. 6.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Immusoft Corp Alpha L-Iduronidase Product Portfolio
  36. 6.6.5 Immusoft Corp Recent Developments
  37. 6.7 JCR Pharmaceuticals Co Ltd
  38. 6.7.1 JCR Pharmaceuticals Co Ltd Company Information
  39. 6.7.2 JCR Pharmaceuticals Co Ltd Business Overview
  40. 6.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolio
  42. 6.7.5 JCR Pharmaceuticals Co Ltd Recent Developments
  43. 6.8 Orchard Therapeutics Plc
  44. 6.8.1 Orchard Therapeutics Plc Company Information
  45. 6.8.2 Orchard Therapeutics Plc Business Overview
  46. 6.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolio
  48. 6.8.5 Orchard Therapeutics Plc Recent Developments
  49. 6.9 Ossianix Inc
  50. 6.9.1 Ossianix Inc Company Information
  51. 6.9.2 Ossianix Inc Business Overview
  52. 6.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ossianix Inc Alpha L-Iduronidase Product Portfolio
  54. 6.9.5 Ossianix Inc Recent Developments
  55. 6.10 Rain Bio Inc
  56. 6.10.1 Rain Bio Inc Company Information
  57. 6.10.2 Rain Bio Inc Business Overview
  58. 6.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Rain Bio Inc Alpha L-Iduronidase Product Portfolio
  60. 6.10.5 Rain Bio Inc Recent Developments
  61. 6.11 RegenxBio Inc
  62. 6.11.1 RegenxBio Inc Company Information
  63. 6.11.2 RegenxBio Inc Business Overview
  64. 6.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 RegenxBio Inc Alpha L-Iduronidase Product Portfolio
  66. 6.11.5 RegenxBio Inc Recent Developments
  67. 6.12 Tega Therapeutics Inc
  68. 6.12.1 Tega Therapeutics Inc Company Information
  69. 6.12.2 Tega Therapeutics Inc Business Overview
  70. 6.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolio
  72. 6.12.5 Tega Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Alpha L-Iduronidase Sales by Country
  2. 7.1.1 North America Alpha L-Iduronidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alpha L-Iduronidase Sales by Country (2021-2026)
  4. 7.1.3 North America Alpha L-Iduronidase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alpha L-Iduronidase Market Size by Country
  6. 7.2.1 North America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alpha L-Iduronidase Market Size by Country (2021-2026)
  8. 7.2.3 North America Alpha L-Iduronidase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alpha L-Iduronidase Sales by Country
  2. 8.1.1 Europe Alpha L-Iduronidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alpha L-Iduronidase Sales by Country (2021-2026)
  4. 8.1.3 Europe Alpha L-Iduronidase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alpha L-Iduronidase Market Size by Country
  6. 8.2.1 Europe Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alpha L-Iduronidase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alpha L-Iduronidase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alpha L-Iduronidase Sales by Country
  2. 9.1.1 Asia-Pacific Alpha L-Iduronidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alpha L-Iduronidase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alpha L-Iduronidase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alpha L-Iduronidase Market Size by Country
  6. 9.2.1 Asia-Pacific Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alpha L-Iduronidase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alpha L-Iduronidase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alpha L-Iduronidase Sales by Country
  2. 10.1.1 South America Alpha L-Iduronidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alpha L-Iduronidase Sales by Country (2021-2026)
  4. 10.1.3 South America Alpha L-Iduronidase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alpha L-Iduronidase Market Size by Country
  6. 10.2.1 South America Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alpha L-Iduronidase Market Size by Country (2021-2026)
  8. 10.2.3 South America Alpha L-Iduronidase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alpha L-Iduronidase Sales by Country
  2. 11.1.1 Middle East and Africa Alpha L-Iduronidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alpha L-Iduronidase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alpha L-Iduronidase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alpha L-Iduronidase Market Size by Country
  6. 11.2.1 Middle East and Africa Alpha L-Iduronidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alpha L-Iduronidase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alpha L-Iduronidase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alpha L-Iduronidase Value Chain Analysis
  2. 12.1.1 Alpha L-Iduronidase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alpha L-Iduronidase Production Mode & Process
  7. 12.2 Alpha L-Iduronidase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alpha L-Iduronidase Distributors
  10. 12.2.3 Alpha L-Iduronidase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst